PropertyValue
?:abstract
  • BACKGROUND: There are limited data on Coronavirus disease 2019 (COVID-19) in solid organ transplant patients, especially in heart transplant recipients, with only a few case reports and case series described so far. Heart transplant recipients may be at particular high risk due to their comorbidities and immunosuppressed state. CASE PRESENTATION: This report describes the clinical course and the challenging management of early COVID-19 infection in two heart transplant recipients who tested positive for the SARS-CoV-2 virus in the perioperative period of the transplant procedure. The two patients developed a severe form of the disease and ultimately died despite the initiation of an antiviral monotherapy with hydroxychloroquine coupled with the interruption of mycophenolate mofetil. CONCLUSIONS: These two cases illustrate the severity and poor prognosis of COVID-19 in the perioperative period of a heart transplant. Thorough screening of donors and recipients is mandatory, and the issue of asymptomatic carriers needs to be addressed. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-05793-6.
?:creator
?:doi
?:doi
  • 10.1186/s12879-021-05793-6
?:journal
  • BMC_Infect_Dis
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/0d22cd81bf8835d1affa5520923e5fdd3ad675e4.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7816134.xml.json
?:pmcid
?:pmid
?:pmid
  • 33472599.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Clinical course and challenging management of early COVID-19 infection after heart transplantation: case report of two patients
?:type
?:year
  • 2021-01-20

Metadata

Anon_0  
expand all